Bravo’s “Relative Success with Tabatha” to Ring The Nasdaq Stock Market Closing Bell
Mar 01, 2018 21:15 pm UTC| Business
ADVISORY, March 01, 2018 -- What:Bravo’s “Relative Success with Tabatha” will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Tabatha Coffey, Star of “Relative Success with Tabatha” and...
Guggenheim Energy & Income Fund Announces Quarterly Distribution
Mar 01, 2018 21:14 pm UTC| Business
NEW YORK, March 01, 2018 -- Guggenheim Investments today announced that Guggenheim Energy Income Fund (the “Fund”) (XGEIX) declared its quarterly distribution. The table below summarizes the distribution schedule for...
VirTra Confirms Processing of Previously Announced 1:2 Reverse Split
Mar 01, 2018 21:14 pm UTC| Business
TEMPE, Ariz., March 01, 2018 -- VirTra, Inc. (OTCQX:VTSI), a global provider of training simulators for the law enforcement, military, educational and commercial markets, today announced that the Financial Industry...
INTERNATIONAL AUTOMAKERS SAY U.S. STEEL AND ALUMINUM TARIFFS WILL HARM INDUSTRY
Mar 01, 2018 21:13 pm UTC| Business
Washington, DC, March 01, 2018 -- Statement by John Bozzella, President and CEO, Global Automakers on behalf of Here for America"The Administration's decision to impose substantial steel and aluminum tariffs will harm...
Mar 01, 2018 21:10 pm UTC| Business
RUTLAND, Vt., March 01, 2018 -- Casella Waste Systems, Inc. (NASDAQ:CWST), a regional solid waste, recycling and resource management services company, today reported its financial results for the three and twelve month...
StoneCastle Financial Corp. Reports Fourth Quarter 2017 Results
Mar 01, 2018 21:10 pm UTC| Business
NEW YORK, March 01, 2018 -- StoneCastle Financial Corp. (Nasdaq:BANX) (“StoneCastle Financial” or the “Company”), an investment company registered with the Securities and Exchange Commission (“SEC”), today announced...
Mar 01, 2018 21:10 pm UTC| Business
BURLINGAME, Calif., March 01, 2018 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies,...